Endurant Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Endurant Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-540,657	Closed	-$1.5M	–	63
2023 Q1	$1.5M	Buy	540,657 +257,722	+91%	+$736K	0.77%	31
2022 Q4	$976K	Buy	+282,935	New	+$808K	0.4%	38
2019 Q3	–	Sell	-143,752	Closed	-$1.6M	–	62
2019 Q2	$1.6M	Buy	143,752 +122,495	+576%	+$1.4M	0.63%	37
2019 Q1	$283K	Buy	+21,257	New	+$284K	0.11%	67

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Endurant Capital Management's GRTS Position: Q2 2023 in Review

Endurant Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 540,657 shares — an estimated $1.5M sold.

Endurant Capital Management first reported a position in GRTS in Q1 2019 and held it in 4 quarters. The position peaked at $1.6M in Q2 2019. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

Endurant Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Endurant Capital Management sold 540,657 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $1.5M.
Endurant Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Endurant Capital Management's Gritstone bio, Inc. Common Stock position peaked at $1.6M in Q2 2019.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on Endurant Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.